Thu.Dec 01, 2022

article thumbnail

Five Things Pharmacists Should Know About Ventilator Associated Pneumonia (VAP)

IDStewardship

In this article a pharmacist with advanced training and experience in infectious diseases discusses five things pharmacists should know about ventilator associated pneumonia (VAP). Authored By: Lucia Rose, PharmD, BCIDP. Article Posted 1 December 2022.

Hospitals 275
article thumbnail

Non-toxic and addiction free: The promise of a new pain med

PharmaVoice

Why South Rampart Pharma’s novel new molecule could be a key to solving the global pain epidemic

94
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Machine Learning Helps Predict Which Patients Respond to Immunotherapy

Pharmacy Times

DeepTCR system showed efficacy as a predictive clinical tool and provided information on the biological mechanisms that underlie how patients respond to immunotherapy.

132
132
article thumbnail

5 final FDA action dates to watch this year

PharmaVoice

A potential flurry of regulatory activity could be on the horizon yet this year — and several key drug approvals are at stake

FDA 83
article thumbnail

FDA Approves First-in-Class Microbiota-Based Live Biotherapeutic for C. Difficile Infection

Pharmacy Times

Live-jslm (Rebyota; Ferring Pharmaceuticals) is indicated for the prevention of recurring Clostridioides difficile infection among patients 18 years of age and older after an antibiotic treatment.

FDA 114
article thumbnail

As major hospitals now bill for some patient-provider messaging, the move could usher wider adoption

Fierce Healthcare

As major hospitals now bill for some patient-provider messaging, the move could usher wider adoption. dmuoio. Thu, 12/01/2022 - 17:48

article thumbnail

Monkeypox Vaccine Modeling Study Results Provide Road Map for Vaccination

Pharmacy Times

Investigators model 2 hypothetical cities as interconnected networks with a combined population of 100,000 bisexual, gay, and other men who have sex with men.

Vaccines 113

More Trending

article thumbnail

COVID-19 Found to Elevate Risk of Seizures More Than Influenza

Pharmacy Times

Individuals who had COVID-19 were 55% more likely to develop epilepsy or seizures over the following 6 months than those who had influenza.

109
109
article thumbnail

UnitedHealth, American Nurses Foundation team on pilot to tackle nurse burnout

Fierce Healthcare

UnitedHealth, American Nurses Foundation team on pilot to tackle nurse burnout. pminemyer. Thu, 12/01/2022 - 16:56

97
article thumbnail

Study: More Than Half of US Adults Not Aware of Link Between Alcohol, Cancer

Pharmacy Times

Data suggest that few US adults are aware that wine can increase the risk of cancer.

109
109
article thumbnail

With FDA nod for its fecal microbiome therapy, Ferring becomes No. 1 in No. 2

Fierce Pharma

With FDA nod for its fecal microbiome therapy, Ferring becomes No. 1 in No. kdunleavy. Thu, 12/01/2022 - 10:14

FDA 94
article thumbnail

Understanding the Origins and How to Heal From Codependency

Pharmacy Times

Commonly known as “relationship addiction,” co-dependency involves emotional, spiritual, physical, or mental enmeshment with a loved one.

109
109
article thumbnail

Senators to Medicare Advantage plans: Get your provider directories in order

Fierce Healthcare

Senators to Medicare Advantage plans: Get your provider directories in order. rking. Thu, 12/01/2022 - 16:41

92
article thumbnail

FDA Grants Orphan Drug Designation to ZielBio’s ZB131 for Cholangiocarcinoma

Pharmacy Times

The investigational drug is a monoclonal antibody with a high affinity and specificity for cancer-specific plectin, a cell surface protein that correlates with aggressive tumors and poor prognosis.

FDA 104
article thumbnail

Eli Lilly dumps Innovent's PD-1 after FDA rebuff, nixing high-profile Chinese cancer drug

Fierce Pharma

Eli Lilly dumps Innovent's PD-1 after FDA rebuff, nixing high-profile Chinese cancer drug. Thu, 12/01/2022 - 15:03

FDA 91
article thumbnail

Pharmacists Participating in Advanced Pain Management Modalities for Refractory Pain

Pharmacy Times

Patient selection is a key factor in the safe and effective administration of advanced pain management modalities.

103
103
article thumbnail

Rough investments, rising costs push Cleveland Clinic's 9-month losses past $1.5B

Fierce Healthcare

Rough investments, rising costs push Cleveland Clinic's 9-month losses past $1.5B. dmuoio. Thu, 12/01/2022 - 15:00

91
article thumbnail

Domvanalimab Combination Shows Clinically Meaningful Progression-Free Survival in Lung Cancer

Pharmacy Times

Data from the fourth interim analysis of the ARC-7 trial shows that a combination of Fc-silent anti-TIGIT and anti-PD-1 molecules are effective for objective response rates in certain lung cancers.

103
103
article thumbnail

PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex

Fierce Pharma

PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex. ntaylor. Thu, 12/01/2022 - 11:05

91
article thumbnail

Steps to building a more patient-centric industry

Pharma Phorum

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials.

article thumbnail

Roche, having shared data with regulators, unwraps results of subcutaneous Tecentriq phase 3 trial

Fierce Pharma

Roche, having shared data with regulators, unwraps results of subcutaneous Tecentriq phase 3 trial. ntaylor. Thu, 12/01/2022 - 09:45

87
article thumbnail

US FDA approves Ferring’s Rebyota for Clostridioides difficile infection

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Ferring Pharmaceuticals’ faecal microbiota product, Rebyota, to prevent Clostridioides difficile infection (CDI) recurrence in people aged 18 years and above.

FDA 87
article thumbnail

FDA approves Ferring’s first-in-class microbiota-based live biotherapeutic

Pharmafile

Switzerland-based Ferring Pharmaceuticals announced the FDA has approved its biotherapeutic REBYOTA®, indicated for the prevention of recurrence of Clostridioides difficile infection (CDI) in patients over the age of eighteen, following antibiotic treatment.

FDA 60
article thumbnail

Is Digital Health Closing Gaps in Health Equity?

Fierce Healthcare

Is Digital Health Closing Gaps in Health Equity? ncapone. Thu, 12/01/2022 - 12:54

81
article thumbnail

Pulmonx secure Japanese approval for Zephyr Valve for COPD/emphysema

Pharmafile

Pulmonx, a US-based medical technology company, has secured approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for its Zephyr Endobronchial Valve, used to treat patients with severe chronic obstructive pulmonary disease (COPD) or emphysema. read more. Medical Communications

article thumbnail

Texas docs file latest legal challenge to surprise billing rule, arguing arbitration process unfair

Fierce Healthcare

Texas docs file latest legal challenge to surprise billing rule, arguing arbitration process unfair. rking. Thu, 12/01/2022 - 14:43

80
article thumbnail

Eli Lilly’s COVID-19 drug bebtelovimab loses FDA authorisation

Pharmafile

The FDA have announced that Eli Lilly’s COVID-19 drug bebtelovimab is not authorised for emergency use in the US, as it is not expected to neutralise the dominant Omicron BQ.1 and BQ.1.1 subvariants.

FDA 56
article thumbnail

Can VR technology make physical therapy fun? – the pharmaphorum podcast

Pharma Phorum

In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock chats with Gita Barry, EVP and GM of Immersive Healthcare at Penumbra, a therapeutic VR company.

79
article thumbnail

Could acoziborole eliminate sleeping sickness in Africa?

European Pharmaceutical Review

Results from a Phase II/III study , published in The Lancet , showed a single, oral dose of acoziborole was up to 95 percent successful in treating sleeping sickness (human African trypanosomiasis). About the Phase II/III study.

article thumbnail

Omicron wave greatly increased infant hospitalization, says CDC

Fierce Healthcare

Omicron wave greatly increased infant hospitalization, says CDC. fdiamond. Thu, 12/01/2022 - 12:02

article thumbnail

mRNA non-vaccine therapeutics to generate $2 billion by 2028

European Pharmaceutical Review

According to GlobalData’s recent report , a total of five marketed messenger RNA (mRNA) non-vaccine products by 2028 will generate over $2 billion, generated by the approval of pipeline agents.

article thumbnail

Elon Musk’s Neuralink to conduct human trials in 2023

Pharmafile

Neuralink owner Elon Musk announced that he has submitted paperwork to the FDA which he hopes will allow Neuralink to undertake human trials in 2023.

FDA 52
article thumbnail

Botanical Solution Inc. (BSI) & Croda Pharma Partnership Agreement to Accelerate Production for GMP QS-21  

Pharma Mirror

QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications. Botanical Solution Inc.

article thumbnail

First faecal microbiota product approved for C. diff

European Pharmaceutical Review

Rebyota, the first faecal microbiota product to prevent recurrence of Clostridioides difficile infection (CDI) in people 18 years and older after being given antibiotics for recurrent CDI, has been approved by the US Food and Drug Administration (FDA).

article thumbnail

UpStream nabs $140M to expand nationwide, scale up value-based care services

Fierce Healthcare

UpStream nabs $140M to expand nationwide, scale up value-based care services. agliadkovskaya. Thu, 12/01/2022 - 14:10

67
article thumbnail

Huge inequalities found in access to myeloma clinical trials in Europe, says MPE

Pharma Phorum

Myeloma Patients Europe (MPE) has identified significant inequalities among patients’ access to myeloma clinical trials in Central and Eastern Europe (CEE) in a first-of-its-kind advocacy report.

65
article thumbnail

Case Study: Use of Disease-Modifying Therapy in Elderly Patients With Multiple Sclerosis

Pharmacy Times

With the advent of disease-modifying therapies, the life span of patients with multiple sclerosis has increased dramatically.

65